Lobbying client

KIDNEYCAN

kidney cancer research

Filings
14
Filed by
1
Reported in-house
—
Reported by firms
$240,000

Reported lobbying by year

The larger of in-house and firm-reported each year, $ thousands 2022 to 2025

Filings

4 filings for 2023, newest first.
Filing Filed by Amount
4th Quarter - Report
4th Quarter 2023
CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C. $20,000 reported
3rd Quarter - Report
3rd Quarter 2023
CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C. $20,000 reported
2nd Quarter - Report
2nd Quarter 2023
CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C. $20,000 reported
1st Quarter - Report
1st Quarter 2023
CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C. $20,000 reported

Filed by

Each firm that has reported for this client, and the client itself where it lobbies in-house, with the reports filed and the amounts they disclose.

FirmReportsAmount
CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C. 13 $240,000

Issues lobbied

How many report sections named each issue, counting the current version of each report.

IssueCodeMentions
Medical/Disease Research/Clinical Labs MED 14

Bills named in its filings

Bill numbers found in the filers' descriptions, most often named first.

BillCongressTimes named
H.R. 9029 118th 3
H.R. 5894 118th 3
S. 4942 118th 2
H.R. 8295 117th 2
H.R. 9029 119th 1
H.R. 5304 119th 1
H.R. 2882 118th 1
H.R. 2617 117th 1

From reports filed under the Lobbying Disclosure Act. Firms report what each client paid them; an organisation lobbying for itself reports its own expenses. Amounts count the current version of each report once.